Medical masks are required during direct contact with patients and in patient waiting areas. Learn More
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Air Date: November 24, 2020 | Length: 36:58
Share this episode:
Almost 20 years ago, a hallway conversation kickstarted Dr. Mansoor Husain's journey in helping create and test a new diabetes drug that reduces the risk of heart disease. In 2019, the award-winning physician-scientist at the Ted Rogers Centre for Heart Research and Peter Munk Cardiac Centre published the findings of a landmark trial proving the drug's safety and reduction in cardiovascular-related mortality, bringing a new therapy into the fold for patients with diabetes – who are two to four times more likely to die from cardiovascular problems than those without it.
In this episode of Behind the Breakthrough, Dr. Husain brings the listener into his lab, where he aims to understand more about the molecular mechanisms behind heart disease. He shares how a Nylon experiment in a high school chemistry class sparked his love for science and ultimately led him to medical school, and what keeps him motivated after 25 years as a scientist.
"I believe that being in the clinic makes a better scientist, and being in the lab makes me a better doctor."
A specialist in cardiovascular disease and nuclear cardiology, Dr. Mansoor Husain is the executive director of the Ted Rogers Centre for Heart Research and a cardiologist at the Peter Munk Cardiac Centre. His past affiliations include leadership positions at the Toronto General Hospital Research Institute, Hypertension Canada and the Heart & Stroke/Richard Lewar Centre of Excellence at the University of Toronto.
Dr. Husain's extensive research focuses on elucidating the molecular bases of cardiovascular diseases – including diabetes and heart failure – and identifying therapeutic targets involved in pathophysiology. A Heart & Stroke Foundation "career investigator" and Hypertension Canada "senior investigator," he has been recognized by research prizes from the Clinical Research Society of Toronto, the University of Toronto, the University of Manitoba, and the Ontario Premier's Research Excellence Award.
Studying medicine at the University of Alberta, Dr. Husain was awarded a gold medal for outstanding merit in 1986. After residencies in internal medicine and cardiology at the University of Toronto, Dr. Husain undertook postdoctoral studies in the department of biology at the Massachusetts Institute of Technology (1993-1997), and the joint program in nuclear medicine at Harvard Medical School. Dr. Husain returned to the University of Toronto in 1997.
